Click Chemistry on Azidoproline: High‐Affinity Dual Antagonist for HIV‐1 Envelope Glycoprotein gp120
Citations Over TimeTop 23% of 2005 papers
Abstract
High affinity dual antagonist: The envelope glycoprotein gp120 of HIV-1 mediates the first steps of viral entry into the host cell. An azidoproline-based peptide conjugate 1 blocks the interaction of gp120 with both the CD4 cell-surface receptor and 17b (an antibody surrogate of the CCR5 co-receptor). It represents a potentially effective approach in preventing HIV infection. Supporting information for this article is available on the WWW under http://www.wiley-vch.de/contents/jc_2452/2006/z500037_s.pdf or from the author. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
Related Papers
- → Studies of Reversible Conjugate Additions(2013)61 cited
- → Rapamycin enhances aplaviroc anti-HIV activity: Implications for the clinical development of novel CCR5 antagonists(2009)15 cited
- → Synergistic inhibition of R5 HIV-1 by maraviroc and CCR5 antibody HGS004 in primary cells: implications for treatment and prevention(2011)12 cited
- → Recent advances of CCR5 antagonists(2006)5 cited
- → Effects of Some Auxins on IAA-Amino Acid Conjugate Formation in Carrot Tissues Transformed with Ti Plamids.(1993)2 cited